PET scan study using a cancer-targeting tracer
Part of Blood & lymphatic, Brain & nervous system, Cancer, Genetic & congenital, Heart & circulation, Hormones & metabolism, Immune system & allergy, Infections clinical trials.
This trial tests a PET scan that uses a radioactive tracer (fluorothymidine) to help doctors see cancer in the body. It may help your care team better understand where cancer is and how it is behaving.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed solid tumor or blood cancer, or you are getting a biopsy or surgery for a new suspicious mass
- You can lie still during the PET scan
- Your body size fits safely in the PET scanner opening
- You are not pregnant
- You are not breastfeeding (nursing)
- If you can get pregnant, you use reliable birth control during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special PET scan to take pictures of certain solid tumors. The scan uses a new dye that may help doctors see the tumors more clearly. You may be eligible if you have one of the listed cancers and are between 18 and 75 years old with good daily function.
This trial tests a PET scan (a type of imaging) that targets cells in the body that help support cancers. It may help doctors better see where cancer-associated cells are located, which could guide future cancer care.
This early-phase study uses PET/CT scans to see how well a new radioactive tracer (a tiny dose of a special material) highlights solid tumors in the body. It may help researchers learn whether this tracer can better find and track tumor spots seen on standard scans.
This Phase 3 study tests how well a special PET/CT scan medicine (a slightly modified sugar) helps doctors investigate your condition. The goal is to improve how diseases like cancer, brain disorders, heart problems, or infection/inflammation are evaluated.
This Phase 1 study tests whether a new PET imaging tracer (a small amount of radioactive medicine) is safe and how it moves through the body. It’s mainly for adults with cancer who have signs of inflammation or possible immune side effects, so doctors can see what’s happening in the body.
This trial tests a new type of PET scan that uses a special tracer to find lung tumors. The goal is to see if this scan can better detect cancer cells, which may help doctors plan the best treatment for you.
Hear when a new Brain and Central Nervous System Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.